Cargando…
Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1
Genetic, epigenetic, and environmental factors contribute to the multifactorial disorder progressive supranuclear palsy (PSP). Here, we study epigenetic changes by genome-wide analysis of DNA from postmortem tissue of forebrains of patients and controls and detect significant (P < 0.05) methylati...
Autores principales: | Weber, Axel, Schwarz, Sigrid C., Tost, Jörg, Trümbach, Dietrich, Winter, Pia, Busato, Florence, Tacik, Pawel, Windhorst, Anita C., Fagny, Maud, Arzberger, Thomas, McLean, Catriona, van Swieten, John C., Schwarz, Johannes, Vogt Weisenhorn, Daniela, Wurst, Wolfgang, Adhikary, Till, Dickson, Dennis W., Höglinger, Günter U., Müller, Ulrich |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6062504/ https://www.ncbi.nlm.nih.gov/pubmed/30050033 http://dx.doi.org/10.1038/s41467-018-05325-y |
Ejemplares similares
-
An autopsy-confirmed case of progressive supranuclear palsy with predominant postural instability
por: Kurz, Carolin, et al.
Publicado: (2016) -
iPS Cell-Based Model for MAPT Haplotype as a Risk Factor for Human Tauopathies Identifies No Major Differences in TAU Expression
por: Strauß, Tabea, et al.
Publicado: (2021) -
Clinical Conditions “Suggestive of Progressive Supranuclear Palsy”—Diagnostic Performance
por: Grimm, Max-Joseph, et al.
Publicado: (2020) -
Distribution patterns of tau pathology in progressive supranuclear palsy
por: Kovacs, Gabor G., et al.
Publicado: (2020) -
Does the Anti‐Tau Strategy in Progressive Supranuclear Palsy Need to Be Reconsidered? No
por: Höglinger, Günter U.
Publicado: (2021)